手术机器人收费有了“国家标准” 涵盖37项价格项目、5项加收项及1项扩展项

Core Viewpoint - The National Healthcare Security Administration has released a guideline for pricing surgical and therapeutic auxiliary medical services, establishing a unified national pricing framework for advanced medical technologies such as 3D printing and robotic surgery, aiming to shift from traditional treatment to precision medicine [1][2]. Group 1: Pricing Framework - The guideline includes 37 pricing items, 5 additional charges, and 1 expansion item, which will standardize clinical diagnosis and treatment fees while opening new avenues for the medical device industry [1]. - Previously, the pricing model for surgical robots lacked a unified standard, leading to chaotic fee structures and unreasonable charges, which increased the burden on patients and complicated insurance interventions [2]. Group 2: Clinical Value and Incentives - The new pricing approach is based on clinical contribution, allowing more advanced and precise surgical robots to command higher fees, thus incentivizing innovation and focusing the industry on technological advancements [3]. - The guideline establishes three pricing categories for surgical robots: navigation, participation, and precision execution, ensuring that fees are aligned with the level of clinical contribution [2][3]. Group 3: Remote Surgery Applications - The guideline also clarifies the pricing path for remote surgery, which has been successfully demonstrated with a distance of over 8000 kilometers, showcasing the potential of remote robotic surgery [3]. - The establishment of a "remote surgery auxiliary operation fee" will facilitate the entry of high-quality surgical robots into the market, making advanced medical technology accessible to more patients [4]. Group 4: Future Directions - The National Healthcare Security Administration aims to complete the guideline compilation and promote the basic unification of medical service pricing projects nationwide, ensuring high-quality, efficient, and affordable medical services for the public [4].